|
Real-time Estimate
Tradegate
15:39:36 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 21.47 EUR | -0.83% |
|
-2.41% | +1.90% |
| 01:20pm | Major drugmakers turn to China for licensing deals | RE |
| 01:00pm | Wave Life Sciences Earns $12 Million Milestone as GSK Advances Liver Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,056B | |||||
| 645B | - | ||||
| 465B | |||||
| 368B | |||||
| 335B |
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
